The international classification of childhood cancer

Kramárová, E; Stiller, Charles

doi:10.1002/(sici)1097-0215(19961211)68:6<759::aid-ijc12>3.0.co;2-w

Cited by 307 publications

(78 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…All osteosarcoma cases inclusion criteria were based on the International Classification of Childhood Cancers (ICCC)9 and/or the International Classification of Disease for Oncology (ICD‐O‐3),10 and the anatomic site codes and all histology subtypes were classified as described by ICD‐O‐3 codes (C40.0‐C41.9) and pathology (ICD‐O‐3 codes 9180‐9186, 9192‐9194) 11…”

Section: Methodsmentioning

confidence: 99%

Increased survival of patients aged 0‐29 years with osteosarcoma: A period analysis, 1984‐2013

Sun

et al. 2018

Cancer Medicine

View full text Add to dashboard Cite

PurposeOsteosarcoma is the most common primary malignancy of bone, and typically occurs among children and adolescence. This study aims to evaluate treatment outcomes among children, adolescents and young adults with osteosarcoma over the three decades by the changes in the long‐term relative survival.MethodsOsteosarcoma incidence and relative survival data from Surveillance, Epidemiology, and End Results (SEER) registries during 1984‐2013 were analyzed. The survival differences over three decades, age, sex, race, and socioeconomic status (SES) were assessed by comparing Kaplan‐Meier curves.ResultsThe overall incidence of osteosarcoma kept relatively stable with 0.4 per 100 000 in the three decades with the peak incidence occurring in the aged 10‐19 group. The 10‐year relative survival rate (RSR) increased from 57.7% to 61.0% in the three decades, with the greatest increase in the aged 0‐9 group from 48.2% to 65.7%. The 10‐year RSR improved from 54.1% to 61.5% in males, and from 62.4% to 63.0% in females, respectively, in the three decades. Furthermore, survival dramatically improved from 30% to 60% in the high‐poverty group over the three decades.ConclusionThis study demonstrated that the overall incidence of osteosarcoma remained stable, with an improvement in survival in the three decades. The improved survival was greater in males than in females in the three decades. Furthermore, the survival significantly increased in high‐poverty group, which was attributed to increasing improved health care system and patients with low finance can also have access to receiving effective and consistent treatment without distinction.

show abstract

Section: Methodsmentioning

confidence: 99%

Increased survival of patients aged 0‐29 years with osteosarcoma: A period analysis, 1984‐2013

Sun

et al. 2018

Cancer Medicine

View full text Add to dashboard Cite

show abstract

“…Procedures for data collection, follow-up and classification as well as criteria for inclusion in the CCRP database have been reported previously [39]. Cancer site, morphology and behavior were coded according to the International Classification of Disease for Oncology (ICD-O-2) [23], and tumor types were grouped according to the International Classification of Childhood Cancer (ICCC) [16]. Intracranial neoplasms of benign and unspecified histology were included; angiomas (even if intracranial) and hystiocytosis X were excluded.…”

Section: Methodsmentioning

confidence: 99%

Time trends and prognostic factors for survival from childhood cancer: a report from the Childhood Cancer Registry of Piedmont (Italy)

et al. 2006

View full text Add to dashboard Cite

Survival after childhood cancer has been improving since the late 1970s in most developed countries. The Childhood Cancer Registry of Piedmont has been recording malignant tumors in children (0-14 years) throughout Piedmont since 1967. The present paper is based on the records of the 2,970 children diagnosed during the period 1970-2001; survival rates are estimated up to June 30, 2004. Based on records from the Registrar Offices of the relevant towns of residence, 1,698 children were reported to be alive, 1,252 deceased, and 20 were of unknown vital status. Over the period 1970-2001, 5-year survival rates for all tumor types combined showed a statistically significant increasing trend (p<0.0001). For acute lymphocytic leukemia, the survival rate increased steadily from 24.7% (95% CI 15.0-34.3) in 1970-1974 to 87.8% (82.1-93.6) in 1995-1999. Five-year survival rates for central nervous system tumors increased from 32.8% (21.0-44.6) in 1970-1974 to 80.3% (72.6-88.0) in 1990-1994 and decreased thereafter. Age of less than 1 year at time of diagnosis was a favorable prognostic factor for neuroblastoma and ganglioneuroblastoma. The extent of disease at diagnosis was related to prognosis for neuroblastoma and ganglioneuroblastoma and other selected solid tumors. A white blood cell count greater than 50,000 x 10(6) cells/l was associated with decreased survival in children with acute lymphocytic leukemia and acute non-lymphocytic leukemia. We have found positive trends in survival for all tumor types in Piedmont, similar to those reported by other population-based cancer registries. Age, extent of disease, and white blood cell count at diagnosis are prognostic factors for selected cancer sites.

show abstract

“…The classification of diseases is based on the International Classification of Childhood Cancer (ICCC), 6 which refers to the International Classification of Diseases for Oncology, 2nd edition (ICD-O-2) coding of morphology and topography. 11 ICCC determined that all incidents of morphologically malignant 12 which includes germ cell tumors, also is based mainly on the ICD-O-2 morphology code.…”

Section: Methodsmentioning

confidence: 99%

“…4,5 Meanwhile, the diseases that are to be included in the group of childhood brain tumors have been defined, 6 and a recent comprehensive overview of childhood malignancies has provided a reliable comparison of incidence rates of childhood CNS tumors. 1 This article presents epidemiologic data on the incidence of pediatric brain tumors and patient survival based on data from the German Childhood Cancer Registry (GCCR).…”

mentioning

confidence: 99%